Sermorelin telehealth cost: what providers charge and how to evaluate a quote
Sermorelin is a synthetic fragment of growth hormone-releasing hormone. It stimulates the pituitary to produce and release the body's own growth hormone, rather than supplying growth hormone directly. It is prescribed off-label through telehealth and longevity clinics for adult growth-hormone optimisation, body composition, sleep and recovery.
What telehealth providers charge
Publishing an unverified number would be worse than publishing none. When we have captured them, they will appear here with a source and a verification date, exactly like our GLP-1 pricing.
Normalise any quote before you compare it
Because we will not hand you a number we cannot stand behind, the useful thing we can give you is the method — the same one we apply to GLP-1 pricing, where we do hold verified figures.
| Ask for… | Because… |
|---|---|
| The total monthly cost, every fee included | Split billing — medication plus a membership — is the commonest way a price looks lower than it is |
| The ongoing price, not the first month | Introductory rates are customer-acquisition pricing. You pay the ongoing rate eleven months of twelve |
| Whether the price rises with dose | A programme cheapest at the starting dose can be the most expensive at maintenance |
| What happens if you cancel early | On a committed plan this is the question most likely to cost you money |
| Whether labs and shipping are included | 'All-inclusive' is used loosely. Test it against specifics |
| The annual total | Monthly figures are how this is marketed; annual totals are how it is lived |
Frequently asked questions
What does Sermorelin cost through telehealth?
We have not verified a market price. On October 15, 2026, NexLife’s sermorelin injection page showed a regular price of $130.00 and was marked sold out, and Oak Longevity showed sermorelin pricing only after a free assessment. Ask any provider for the total monthly cost, including consultations and supplies, in writing.
Is Sermorelin FDA-approved?
No approved sermorelin product is on the U.S. market as of October 15, 2026. Its approved product, Geref, was discontinued, and FDA determined in 2013 that it was not withdrawn for safety or effectiveness reasons. Sermorelin is in none of FDA’s interim 503A compounding categories.
Does Sermorelin work?
Sermorelin prompts the pituitary to release growth hormone, so it can raise growth-hormone and IGF-1 levels. Evidence that this improves body composition, sleep or ageing in healthy adults is thin. We have not re-read the clinical literature for this update and cite no trial.
Sources
- U.S. Food and Drug Administration — approved labels and compounding guidance for this molecule.
- PubMed / NIH — indexed human clinical literature.
- ClinicalTrials.gov — registered trials, where they exist.
- Our source hierarchy and pricing-verification methodology.